Your browser doesn't support javascript.
loading
Rationale for Use of Sphingosine-1-Phosphate Receptor Modulators in COVID-19 Patients: Overview of Scientific Evidence.
Hach, Thomas; Shakeri-Nejad, Kasra; Bigaud, Marc; Dahlke, Frank; de Micco, Massimiliano; Petricoul, Olivier; Graham, Gordon; Piani-Meier, Daniela; Turrini, Renato; Brinkmann, Volker; Nicoletti, Ferdinando.
Afiliación
  • Hach T; Patient Engagement, Novartis Pharma AG, Basel, Switzerland.
  • Shakeri-Nejad K; Department of Clinical Pharmacology; Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Bigaud M; Department of Autoimmunity, Transplantation & Inflammation; Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Dahlke F; Patient Engagement, Novartis Pharma AG, Basel, Switzerland.
  • de Micco M; Novartis Farma S.p.A., Origgio, Italy.
  • Petricoul O; Department of Neuroscience; Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Graham G; Patient Engagement, Novartis Pharma AG, Basel, Switzerland.
  • Piani-Meier D; Patient Engagement, Novartis Pharma AG, Basel, Switzerland.
  • Turrini R; Department of Autoimmunity, Transplantation & Inflammation; Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Brinkmann V; Independent Consultant, Freiburg, Germany.
  • Nicoletti F; Department of Physiology and Pharmacology, University Sapienza of Rome, Rome, Italy.
J Interferon Cytokine Res ; 43(6): 246-256, 2023 Jun.
Article en En | MEDLINE | ID: mdl-36454249

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Moduladores de los Receptores de fosfatos y esfingosina 1 / COVID-19 / Esclerosis Múltiple Límite: Humans Idioma: En Revista: J Interferon Cytokine Res Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Moduladores de los Receptores de fosfatos y esfingosina 1 / COVID-19 / Esclerosis Múltiple Límite: Humans Idioma: En Revista: J Interferon Cytokine Res Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Estados Unidos